XML 18 R5.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements of Changes in Shareholders' Deficit - USD ($)
Preferred Stock [Member]
Series A Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Dec. 31, 2019 $ 420 $ 15 $ 25,328,861 $ (25,684,927) $ (355,631)
Beginning balance, shares at Dec. 31, 2019 42,030,331 1,521,444      
Beginning balance, shares to be issued at Dec. 31, 2019   10,400      
Common shares issued in settlement of restricted stock units and award of stock bonuses $ 1 (1)
Common shares issued in settlement of restricted stock units and award of stock bonuses, shares   55,400      
Common shares issued or to be issued on settlement of restricted stock units and award of stock bonuses, shares to be issued   (10,400)      
Fair value of vested restricted stock units awarded to employees 25,163 25,163
Fair value of vested stock options accrued in 2019 and issued to employees and directors in 2020 503,466 503,466
Fair value of vested stock options granted to employees and directors 252,020 252,020
Net loss (1,758,716) (1,758,716)
Ending balance, value at Dec. 31, 2020 $ 420 $ 16 26,109,509 (27,443,643) (1,333,698)
Ending balance, shares at Dec. 31, 2020 42,030,331 1,576,844      
Ending balance, shares to be issued at Dec. 31, 2020        
Common shares issued in settlement of legal dispute 67,000 67,000
Common shares issued in settlement of legal dispute, shares   6,667      
Fair value of vested stock options granted to employees 298,040 298,040
Fair value of vested stock options granted to directors 21,174 21,174
Issuance of series B preferred stock and warrants, net 927,721 927,721
Receipt of series B preferred stock subscription receivable        
Conversion of series A preferred stock to common $ (420) 420
Conversion of series A preferred stock to common, shares (42,030,331) 2,802      
Issuance of common stock in settlement of accrued interest 67,447 67,447
Issuance of common stock in settlement of accrued interest, shares   7,719      
Issuance of restricted common stock to employee 50,000 50,000
Issuance of restricted common stock to employee, shares   6,803      
Accrued interest on Series B preferred stock (67,447) (67,447)
Net loss (1,337,923) (1,337,923)
Adjustment to redemption value of Series B preferred stock (2,262,847) (2,262,847)
Ending balance, value at Dec. 31, 2021 $ 16 $ 25,211,017 $ (28,781,566) $ (3,570,533)
Ending balance, shares at Dec. 31, 2021 1,600,835